Literature DB >> 9022893

Serum total antioxidant activity after myocardial infarction.

N J Miller1, J D Johnston, C S Collis, C Rice-Evans.   

Abstract

Serum total antioxidant activity (TAA), albumin and uric acid were measured on admission, and for the next 2 days in 56 patients suffering myocardial infarction, 20 of whom received streptokinase. The 'antioxidant gap', the difference between the serum TAA and the sum of the serum albumin and uric acid activity, was calculated. No significant changes in serum total antioxidant activity were observed in either group of patients between admission, day 1 and day 2. However, a decline in the 'antioxidant gap' after myocardial infarction was associated with a significantly higher mortality.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9022893     DOI: 10.1177/000456329703400113

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  6 in total

1.  Method for the measurement of antioxidant activity in human fluids.

Authors:  D Koracevic; G Koracevic; V Djordjevic; S Andrejevic; V Cosic
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

2.  Treatment with the iron chelator, deferoxamine mesylate, alters serum markers of oxidative stress in stroke patients.

Authors:  Magdy Selim
Journal:  Transl Stroke Res       Date:  2009-12-10       Impact factor: 6.829

3.  Erythrocyte caspase-3 and antioxidant defense is activated in red blood cells and plasma of type 2 diabetes patients at first clinical onset.

Authors:  Octavian Savu; Ovidiu Marius Bradescu; Cristian Serafinceanu; Liviu Iosif; Constantin Ionescu Tirgoviste; Irina Stoian
Journal:  Redox Rep       Date:  2013-03-06       Impact factor: 4.412

4.  Stability of the Hsp90 inhibitor 17AAG hydroquinone and prevention of metal-catalyzed oxidation.

Authors:  Wenchang Guo; David Siegel; David Ross
Journal:  J Pharm Sci       Date:  2008-12       Impact factor: 3.534

5.  Cardiovascular risk factors and total serum antioxidant capacity in healthy men and in men with coronary heart disease.

Authors:  Anna Gawron-Skarbek; Jacek Chrzczanowicz; Joanna Kostka; Dariusz Nowak; Wojciech Drygas; Anna Jegier; Tomasz Kostka
Journal:  Biomed Res Int       Date:  2014-08-11       Impact factor: 3.411

6.  A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics.

Authors:  Marilena Gilca; Gabriela Piriu; Laura Gaman; Corina Delia; Liviu Iosif; Valeriu Atanasiu; Irina Stoian
Journal:  Psychopharmacology (Berl)       Date:  2014-05-29       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.